S4 Medical, a Columbus, Ohio-based innovative medical device company, raised a new funding of undisclosed amount.
Investors included Ohio Innovation Fund (OIF), ProMedica, Plug and Play, Valley Growth Ventures, Jumpstart, North Coast Angel Fund, and individual angel investors.
This new funding will enable the company to continue to develop its device.
Led by Co-Inventor and Co-Founder Dr. Emile Daoud, Chief of Cardiac Electrophysiology at The Ohio State University Wexner Medical Center, and William Fuller, Co-founder and CEO, S4 Medical focuses on protecting the esophagus from thermal damage during catheter ablation procedures. The device being developed by the company, called ESolution, is inserted through the mouth into the esophagus and utilizes a proprietary method to deviate the esophagus away from potential thermal injury. S4 Medical completed its first human studies in seven patients in Argentina.
FinSMEs
17/02/2020